Acute injection of asp in the third ventricle inhibits food intake and locomotor activity in rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 301, Issue 1, 2011, Pages

  Roy, Christian ^a   Roy, Marie Claude ^a   Gauvreau, Danny ^a   Poulin, Anne Marie ^a   Tom, Fun Qun ^a   Timofeeva, Elena ^a   Richard, Denis ^a   Cianflone, Katherine ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Acylation stimulating protein; C5l2; Energy metabolism; Proopiomelanocortin

Indexed keywords

ACYLATION STIMULATING PROTEIN; FATTY ACID; NEUROPEPTIDE Y;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; BRAIN THIRD VENTRICLE; CALORIC INTAKE; CANNULA; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID METABOLISM; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHIBITION KINETICS; LOCOMOTION; MALAISE; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TASTE AVERSION; WEIGHT GAIN;

ANIMALS; ANOREXIA; CEREBROSPINAL FLUID; DOWN-REGULATION; EATING; GENE EXPRESSION REGULATION; HUMANS; INJECTIONS, INTRAVENTRICULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MOTOR ACTIVITY; OXYGEN CONSUMPTION; PRO-OPIOMELANOCORTIN; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 79959612285     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00476.2010     Document Type: Article

References (57)

1. Baldo A, Sniderman AD, St Luce S, Zhang XJ, Cianflone K. Signal transduction pathway of acylation stimulating protein: Involvement of protein kinase C. J Lipid Res 36: 1415-1426, 1995.
2. Barnum SR. Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 6: 132-146, 1995.
3. Batsell WR, Best MR. One bottle too many? Method of testing determines the detection of overshadowing and retention of taste aversions. Anim Learn Behav 21: 154-158, 1993.
4. Blundell JE, Gillett A. Control of food intake in the obese. Obes Res 9, Suppl 4: 263S-270S, 2001.
5. Blundell JE, Stubbs RJ, Hughes DA, Whybrow S, King NA. Cross talk between physical activity and appetite control: does physical activity stimulate appetite? Proc Nutr Soc 62: 651-661, 2003.
6. Campbell WD, Lazoura E, Okada N, Okada H. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol Immunol 46: 131-134, 2002.
7. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549, 1995.
8. Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 1609: 127-143, 2003.
9. Cui W, Lapointe M, Gauvreau D, Kalant D, Cianflone K. Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation. Mol Immunol 46: 3207-3217, 2009.
10. Cui W, Paglialunga S, Kalant D, Lu H, Roy C, Laplante M, Deshaies Y, Cianflone K. Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. Am J Physiol Endocrinol Metab 293: E1482-E1491, 2007.
11. Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, Bloom SR. Oxyntomodulin inhibits food intake in the rat. Endocrinology 142: 4244-4250, 2001.
12. Dakin CL, Small CJ, Park AJ, Seth A, Ghatei MA, Bloom SR. Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats. Am J Physiol Endocrinol Metab 283: E1173-E1177, 2002.
13. Duclos M, Timofeeva E, Michel C, Richard D. Corticosterone-dependent metabolic and neuroendocrine abnormalities in obese Zucker rats in relation to feeding. Am J Physiol Endocrinol Metab 288: E254-E266, 2005.
14. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
15. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94: 8878-8883, 1997.
16. Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 226: 963-977, 2001.
17. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53, Suppl 1: S143-S151, 2004.
18. Huang Q, Timofeeva E, Richard D. Regulation of corticotropin-releasing factor and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress. J Endocrinol 191: 179-188, 2006.
19. Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, Monk PN. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. J Biol Chem 278: 11123-11129, 2003.
20. Kalant D, MacLaren R, Cui W, Samanta R, Monk PN, Laporte SA, Cianflone K. C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem 280: 23936-23944, 2005.
21. Kalant D, Phelis S, Fielding BA, Frayn KN, Cianflone K, Sniderman AD. Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. J Lipid Res 41: 1963-1968, 2000.
22. Kim S, Moustaid-Moussa N. Secretory, endocrine and autocrine/paracrine function of the adipocyte. J Nutr 130: 3110S-3115S, 2000.
23. Kotz CM, Teske JA, Billington CJ. Neuroregulation of nonexercise activity thermogenesis and obesity resistance. Am J Physiol Regul Integr Comp Physiol 294: R699-R710, 2008.
24. Lee DK, George SR, Cheng R, Nguyen T, Liu Y, Brown M, Lynch KR, O'Dowd BF. Identification of four novel human G protein-coupled receptors expressed in the brain. Brain Res Mol Brain Res 86: 13-22, 2001.
25. Lesavre PH, Hugli TE, Esser AF, Müller-Eberhard HJ. The alternative pathway C3/C5 convertase: chemical basis of factor B activation. J Immunol 123: 529-534, 1979.
26. Loeffler DA, Brickman CM, Juneau PL, Perry MF, Pomara N, Lewitt PA. Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer's disease. Neurobiol Aging 18: 555-557, 1997.
27. Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, Steere J, Choi SJ, Ghatei MA, Bloom SR. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 140: 244-250, 1999.
28. Mullier A, Bouret SG, Prevot V, Dehouck B. Differential distribution of tight junction proteins suggests a role for tanycytes in blood-hypothalamus barrier regulation in the adult mouse brain. J Comp Neurol 518: 943-962, 2010.
29. Murray I, Havel PJ, Sniderman AD, Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 141: 1041-1049, 2000.
30. Murray I, Sniderman AD, Cianflone K. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57Bl/6 mice. Am J Physiol Endocrinol Metab 277: E474-E480, 1999.
31. Murray I, Sniderman AD, Havel PJ, Cianflone K. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. J Biol Chem 274: 36219-36225, 1999.
32. Ohinata K, Suetsugu K, Fujiwara Y, Yoshikawa M. Suppression of food intake by a complement C3a agonist [Trp5]-oryzatensin(5-9). Peptides 28: 602-606, 2007.
33. Ohinata K, Yoshikawa M. Food intake regulation by central complement system. Adv Exp Med Biol 632: 35-46, 2008.
34. Ohinata K, Inui A, Asakawa A, Wada K, Wada E, Yoshikawa M. Albutensin A and complement C3a decrease food intake in mice. Peptides 23: 127-133, 2002.
35. Paglialunga S, Fisette A, Munkonda M, Gao Y, Richard D, Cianflone K. The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice. BMC Physiol 10: 4, 2010.
36. Paglialunga S, Schrauwen P, Roy C, Moonen-Kornips E, Lu H, Hesselink MK, Deshaies Y, Richard D, Cianflone K. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. J Endocrinol 194: 293-304, 2007.
37. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Orlando, FL: Academic, 2000.
38. Peruzzo B, Pastor FE, Blázquez JL, Amat P, Rodríguez EM. Polarized endocytosis and transcytosis in the hypothalamic tanycytes of the rat. Cell Tissue Res 317: 147-164, 2004.
39. Poulin AM, Timofeeva E. The dynamics of neuronal activation during food anticipation and feeding in the brain of food-entrained rats. Brain Res 1227: 128-141, 2008.
40. Roy C, Paglialunga S, Fisette A, Schrauwen P, Moonen-Kornips E, St-Onge J, Hesselink MK, Richard D, Joanisse DR, Cianflone K. Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet. Am J Physiol Endocrinol Metab 294: E1051-E1059, 2008.
41. Saleh J, Blevins JE, Havel PJ, Barrett JA, Gietzen DW, Cianflone K. Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. Int J Obes Relat Metab Disord 25: 705-713, 2001.
42. Saleh J, Sniderman AD, Cianflone K. Postprandial triacylglycerol clearance in ob/ob and db/db mice: physiological effects of ASP in mouse models of obesity and hypertriglyceridemia (Abstract). Int J Obes Relat Metab Disord 22: S183, 1998.
43. Saleh J, Summers LK, Cianflone K, Fielding BA, Sniderman AD, Frayn KN. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 39: 884-891, 1998.
44. Satoh N, Ogawa Y, Katsuura G, Hayase M, Tsuji T, Imagawa K, Yoshimasa Y, Nishi S, Hosoda K, Nakao K. The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci Lett 224: 149-152, 1997.
45. Schupf N, Williams CA, Hugli TE, Cox J. Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamus. J Neuroimmunol 5: 305-316, 1983.
46. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.
47. Seeley RJ, Woods SC. Monitoring of stored and available fuel by the CNS: implications for obesity. Nat Rev Neurosci 4: 901-909, 2003.
48. Tahiri Y, Karpe F, Tan GD, Cianflone K. Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Nutr Metab (Lond) 4: 11, 2007.
49. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72, 1996.
50. Vettor R, Fabris R, Pagano C, Federspil G. Neuroendocrine regulation of eating behavior. J Endocrinol Invest 25: 836-854, 2002.
51. Welle S. Sympathetic nervous system response to intake. Am J Clin Nutr 62: 1118S-1122S, 1995.
52. Woodruff TM, Costantini KJ, Crane JW, Atkin JD, Monk PN, Taylor SM, Noakes PG. The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J Immunol 181: 8727-8734, 2008.
53. Wu Y, Zhang J, Wen Y, Wang H, Zhang M, Cianflone K. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil Steril 91: 213-219, 2009.
54. Xia Z, Sniderman AD, Cianflone K. Acylation-stimulating Protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem 277: 45874-45879, 2002.
55. Xia Z, Stanhope KL, Digitale E, Simion OM, Chen L, Havel P, Cianflone K. Acylation-stimulating protein (ASP)/complement C3adesArg deficiency results in increased energy expenditure in mice. J Biol Chem 279: 4051-4057, 2004.
56. Xu AW, Kaelin CB, Takeda K, Akira S, Schwartz MW, Barsh GS. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest 115: 951-958, 2005.
57. Yang Y, Lu HL, Zhang J, Yu HY, Wang HW, Zhang MX, Cianflone K. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes (Lond) 30: 439-446, 2006.